home / stock / pulm / pulm quote
Last: | $2.1101 |
---|---|
Change Percent: | 1.37% |
Open: | $2.16 |
Close: | $2.1101 |
High: | $2.16 |
Low: | $2.01 |
Volume: | 23,035 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.1101 | $2.16 | $2.1101 | $2.16 | $2.01 | 23,035 | 07-05-2024 |
$2.19 | $1.99 | $2.19 | $2.19 | $1.99 | 20,418 | 07-04-2024 |
$2.19 | $1.99 | $2.19 | $2.19 | $1.99 | 20,418 | 07-03-2024 |
$2 | $1.9799 | $2 | $2.1 | $1.97 | 71,267 | 07-02-2024 |
$1.96 | $1.98 | $1.96 | $1.98 | $1.9401 | 3,844 | 07-01-2024 |
$1.93 | $1.93 | $1.93 | $1.97 | $1.92 | 12,519 | 06-28-2024 |
$1.95 | $1.91 | $1.95 | $1.9667 | $1.91 | 3,214 | 06-27-2024 |
$1.95 | $1.95 | $1.95 | $1.97 | $1.88 | 6,587 | 06-26-2024 |
$1.95 | $1.9 | $1.95 | $1.98 | $1.9 | 3,928 | 06-25-2024 |
$1.93 | $1.92 | $1.93 | $1.97 | $1.9 | 7,714 | 06-24-2024 |
$1.98 | $1.87 | $1.98 | $1.98 | $1.87 | 7,775 | 06-21-2024 |
$1.9299 | $1.9325 | $1.9299 | $1.96 | $1.88 | 5,137 | 06-20-2024 |
$1.92 | $1.8702 | $1.92 | $1.9826 | $1.8702 | 4,987 | 06-19-2024 |
$1.92 | $1.8702 | $1.92 | $1.9826 | $1.8702 | 4,987 | 06-18-2024 |
$1.95 | $1.91 | $1.95 | $1.96 | $1.9001 | 3,526 | 06-17-2024 |
$1.9177 | $1.9 | $1.9177 | $1.96 | $1.85 | 7,754 | 06-14-2024 |
$1.8899 | $1.92 | $1.8899 | $1.92 | $1.8846 | 3,366 | 06-13-2024 |
$1.8901 | $1.83 | $1.8901 | $1.891 | $1.83 | 3,805 | 06-12-2024 |
$1.916 | $1.91 | $1.916 | $1.94 | $1.851 | 13,820 | 06-11-2024 |
$1.9651 | $1.9 | $1.9651 | $1.97 | $1.9 | 5,783 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...
Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) PR Newswire Orally Inhaled PUR3100 is associated with rapid systemic PK within the therapeutic window and a mean time to Cmax matching intravenously (IV) a...